Anthropic announced the availability of Claude Science, an application that optimizes its large language model for use in scientific laboratories and within the research operations of pharmaceutical companies, marking the first time a large AI developer has released a separate interface and product for scientists, and the company has plans to develop drugs of its own. Separately, President Trump promised to make U.S. prescription drug prices the cheapest in the world, but a closely watched Medicaid pilot program could expose the limits of the buy-in among mid-sized and smaller pharmaceutical companies, as the administration convinced 17 of the largest global drugmakers to offer lower prices comparable to what is paid in other developed countries, referred to as “most-favored-nation” pricing, while mid-size companies account for the development of most new innovative medicines but have different business models than big drugmakers and lack the large portfolio of medicines that make it easier to cut deals.